Cordycepin suppresses integrin/FAK signaling and epithelial-mesenchymal transition in hepatocellular Carcinoma

Anti-Cancer Agents in Medicinal Chemistry

Volumn 14, Issue 1, 2014, Pages 29-34

  Yao, Wen Ling ^a,b   Ko, Bor Sheng ^a,c   Liu, Tzu An ^a   Liang, Shu Man ^a   Liu, Chia Chia ^a   Lu, Yi Jhu ^a   Tzean, Shean Shong ^b   Shen, Tang Long ^b   Liou, Jun Yang ^a,d  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cordycepin; E cadherin; Focal adhesion kinase; Hepatocellular carcinoma; Integrin

Indexed keywords

ALPHA CATENIN; ALPHA3 INTEGRIN; ALPHA6 INTEGRIN; BETA CATENIN; BETA1 INTEGRIN; CORDYCEPIN; FOCAL ADHESION KINASE; INTEGRIN; NERVE CELL ADHESION MOLECULE; UVOMORULIN; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 6;

ARTICLE; CELL CULTURE; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LIVER CELL CARCINOMA; PHOSPHORYLATION; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DEOXYADENOSINES; EPITHELIAL-MESENCHYMAL TRANSITION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INTEGRIN ALPHA3BETA1; INTEGRIN ALPHA6BETA1; LIVER NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84899455589     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/18715206113139990305     Document Type: Article

References (59)

1. Buenz, E.J.; Bauer, B.A.; Osmundson, T.W.; Motley, T.J. The traditional chinese medicine cordyceps sinensis and its effects on apoptotic homeostasis. J. Ethnopharmacol., 2005, 96(1-2), 19-29.
2. Paterson, R.R. Cordyceps: A traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry, 2008, 69(7), 1469-1495.
3. Wu, W.C.; Hsiao, J.R.; Lian, Y.Y.; Lin, C.Y.; Huang, B.M. The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell line. Cancer Chemother. Pharmacol., 2007, 60(1), 103-111.
4. Lee, E.J.; Kim, W.J.; Moon, S.K. Cordycepin suppresses TNF-alpha-induced invasion, migration and matrix metalloproteinase-9 expression in human bladder cancer cells. Phytother. Res., 2010, 24(12), 1755-1761.
5. Chen, Y.; Chen, Y.C.; Lin, Y.T.; Huang, S.H.; Wang, S.M. Cordycepin induces apoptosis of CGTH W-2 thyroid carcinoma cells through the calcium-calpain-caspase 7-PARP pathway. J. Agric. Food Chem., 2010, 58(22), 11645-11652.
6. Lee, H.J.; Burger, P.; Vogel, M.; Friese, K.; Brüning, A. The nucleoside antagonist cordycepin causes DNA double strand breaks in breast cancer cells. Invest. New Drugs, 2012, 30(5), 1917-1925.
7. Chen, L.S.; Stellrecht, C.M.; Gandhi, V. RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells. Br. J. Haematol., 2008, 140(6), 682-691.
8. Matsuda, H.; Akaki, J.; Nakamura, S.; Okazaki, Y.; Kojima, H.; Tamesada, M.; Yoshikawa, M. Apoptosis-inducing effects of sterols from the dried powder of cultured mycelium of Cordyceps sinensis. Chem. Pharm. Bull. (Tokyo), 2009, 57(4), 411-414.
9. Jeong, J.W.; Jin, C.Y.; Park, C.; Hong, S.H.; Kim, G.Y.; Jeong, Y.K.; Lee, J.D.; Yoo, Y.H.; Choi, Y.H. Induction of apoptosis by cordycepin via reactive oxygen species generation in human leukemia cells. Toxicol. In Vitro, 2011, 25(4), 817-824.
10. Kodama, E.N.; McCaffrey, R.P.; Yusa, K.; Mitsuya, H. Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells. Biochem. Pharmacol., 2000, 59(3), 273-281.
11. Thomadaki, H.; Tsiapalis, C.M.; Scorilas, A. The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines. Cancer Chemother. Pharmacol., 2008, 61(4), 703-711.
12. Jen, C.Y.; Lin, C.Y.; Huang, B.M.; Leu, S.F. Cordycepin induced MA-10 mouse leydig tumor cell apoptosis through caspase-9 pathway. Evid. Based Complement. Alternat. Med., 2011, 2011, 984537.
13. Yoshikawa, N.; Kunitomo, M.; Kagota, S.; Shinozuka, K.; Nakamura, K. Inhibitory effect of cordycepin on hematogenic metastasis of B16-F1 mouse melanoma cells accelerated by adenosine-5'-diphosphate. Anticancer Res., 2009, 29(10), 3857-3860.
14. Yoshikawa, N.; Yamada, S.; Takeuchi, C.; Kagota, S.; Shinozuka, K.; Kunitomo, M.; Nakamura, K. Cordycepin (3'-deoxyadenosine) inhibits the growth of B16-BL6 mouse melanoma cells through the stimulation of adenosine A3 receptor followed by glycogen synthase kinase-3beta activation and cyclin D1 suppression. Naunyn Schmiedebergs Arch. Pharmacol., 2008, 377(4-6), 591-595.
15. Nakamura, K.; Yoshikawa, N.; Yamaguchi, Y.; Kagota, S.; Shinozuka, K.; Kunitomo, M. Antitumor effect of cordycepin (3'-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation. Anticancer Res., 2006, 26(1A), 43-47.
16. Thiery, J.P.; Sleeman, J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol., 2006, 7, 131-142.
17. Peinado, H.; Olmeda, D.; Cano, A. Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat. Rev. Cancer., 2007, 7, 415-428.
18. Huber, M.A.; Kraut, N.; Beug, H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol., 2005, 17, 548-558.
19. Jeanes, A.; Gottardi, C.J.; Yap, A.S. Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene, 2008, 27, 6920-6929.
20. Eger, A.; Stockinger, A.; Park, J.; Langkopf, E.; Mikula, M.; Gotzmann, J.; Mikulits, W.; Beug, H.; Foisner, R. Beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene, 2004, 23, 2672-2680.
21. Matsumura, T.; Makino, R.; Mitamura, K. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin. Cancer Res., 2001, 7, 594-599.
22. Kanai, Y.; Ushijima, S.; Hui, A.M.; Ochiai, A.; Tsuda, H.; Sakamoto, M.; Hirohashi, S. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int. J. Cancer., 1997, 71, 355-359.
23. Yang, B.; Guo, M.; Herman, J.G.; Clark, D.P. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am. J. Pathol, 2003, 163, 1101-1107.
24. Han, N.M.; Fleming, R.Y.; Curley, S.A.; Gallick, G.E. Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: Independence from c-src or c-yes activation. Ann. Surg. Oncol., 1997, 4(3), 264-268.
25. Cance, W.G.; Harris, J.E.; Iacocca, M.V.; Roche, E.; Yang, X.; Chang, J.; Simkins, S.; Xu, L. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: Correlation with preinvasive and invasive phenotypes. Clin. Cancer Res., 2000, 6(6), 2417-2423.
26. Owens, L.V.; Xu, L.; Craven, R.J.; Dent, G.A.; Weiner, T.M.; Kornberg, L.; Liu, E.T.; Cance, W.G. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res., 1995, 55(13), 2752-2755.
27. McCormack, S.J.; Brazinski, S.E.; Moore, J.L. Jr.; Werness, B.A; Goldstein, D.J. Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene, 1997, 15(3), 265-274.
28. Tremblay, L.; Hauck, W.; Aprikian, A.G.; Begin, L.R.; Chapdelaine, A.; Chevalier, S. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma. Int. J. Cancer, 1996, 68(2), 164-171.
29. Owens, L.V.; Xu, L.; Dent, G.A.; Yang, X.; Sturge, G.C.; Craven, R.J.; Cance, W.G. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann. Surg. Oncol., 1996, 3(1), 100-105.
30. Beierle, E.A.; Massoll, N.A.; Hartwich, J.; Kurenova, E.V.; Golubovskaya, V.M.; Cance, W.G.; McGrady, P.; London, W.B. Focal adhesion kinase expression in human neuroblastoma: immunohistochemical and real-time PCR analyses. Clin. Cancer Res., 2008, 14(11), 3299-3305.
31. Fujii, T.; Koshikawa, K.; Nomoto, S.; Okochi, O.; Kaneko, T.; Inoue, S.; Yatabe, Y.; Takeda, S.; Nakao, A. Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. J. Hepatol., 2004, 41(1), 104-111.
32. Itoh, S.; Maeda, T.; Shimada, M.; Aishima, S.; Shirabe, K.; Tanaka, S.; Maehara, Y. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin. Cancer Res., 2004, 10(8), 2812-2817.
33. Jan, Y.J.; Ko, B. S.; Hsu, C; Chang, T.C.; Chen, S. C; Wang, J.; Liou, J.Y. Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma. Hum. Pathol, 2009, 40(10), 1384-1390.
34. Ko, B.S.; Jan, Y.J.; Chang, T.C.; Liang, S.M.; Chen, S.C.; Liu, T.A.; Wu, Y.M.; Wang, J.; Liou, J.Y. Upregulation of focal adhesion kinase by 14-3-3s via NFkB activation in hepatocellular carcinoma. Anti-cancer Agents Med. Chem., 2013, 13(4), 555-562.
35. Yuan, Z.; Zheng, Q.; Fan, J.; Ai, K.X.; Chen, J.; Huang, X.Y. Expression and prognostic significance of focal adhesion kinase in hepatocellular carcinoma. J. Cancer Res. Clin. Oncol., 2010, 136(10), 1489-1496.
36. Lau, G.M.; Lau, G.M.; Yu, G.L.; Gelman, I.H.; Gutowski, A.; Hangauer, D.; Fang, J.W. Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro. Dig. Dis. Sci., 2009, 54, 1465-1474.
37. Cai, L.; Han, J.; Zhuo, X.; Xiong, Y.; Dong, J.; Li, X. Overexpression and significance of focal adhesion kinase in hepatocellular carcinoma and its relationship with HBV infection. Med. Oncol, 2009, 26, 409-414.
38. Chen, J.S.; Huang, X.H.; Wang, Q.; Chen, X.L.; Fu, X.H.; Tan, H.X.; Zhang, L.J.; Li, W.; Bi, J. FAK is involved in invasion and metastasis of hepatocellular carcinoma. Clin. Exp. Metastasis, 2010, 27(2), 71-82.
39. Longhurst, CM.; Jennings, L.K. Integrin-mediated signal transduction. Cell Mol. Life Sci., 1998, 54(6), 514-526.
40. Schlaepfer, D.D.; Hunter, T. Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol., 1998, 8(4), 151-157.
41. Schaller, M.D.; Parsons, J.T. Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol, 1994, 6(5), 705-710.
42. Masumoto, A.; Arao, S.; Otsuki, M. Role of beta1 integrins in adhesion and invasion of hepatocellular carcinoma cells. Hepatology, 1999, 29(1), 68-74.
43. Torimura, T.; Ueno, T.; Kin, M.; Inuzuka, S.; Sugawara, H.; Tamaki, S.; Tsuji, R.; Sujaku, K.; Sata, M.; Tanikawa, K. Coordinated expression of integrin alpha6beta1 and laminin in hepatocellular carcinoma. Hum. Pathol, 1997, 28(10), 1131-1138.
44. Torimura, T.; Ueno, T.; Kin, M.; Ogata, R.; Inuzuka, S.; Sugawara, H.; Kurotatsu, R.; Shimada, M.; Yano, H.; Kojiro, M.; Tanikawa, K.; Sata, M. Integrin alpha6beta1 plays a significant role in the attachment of hepatoma cells to laminin. J. Hepatol, 1999, 31(4), 734-740.
45. Nejjari, M.; Hafdi, Z.; Dumortier, J.; Bringuier, A.F.; Feldmann, G.; Scoazec, J.Y. Alpha6beta1 integrin expression in hepatocarcinoma cells: regulation and role in cell adhesion and migration. Int. J. Cancer., 1999, 83(4), 518-525.
46. Fu, B.H.; Wu, Z.Z.; Qin, J. Effects of integrins on laminin chemotaxis by hepatocellular carcinoma cells. Mol Biol. Rep., 2010, 37(3), 1665-1670.
47. Bergamini, C; Sgarra, C; Trerotoli, P.; Lupo, L.; Azzariti, A.; Antonaci, S.; Giannelli, G. Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha6beta4 and alpha3beta1 integrins. Hepatology, 2007, 46(6), 1801-1809.
48. Carloni, V.; Mazzocca, A.; Pantaleo, P.; Cordella, C; Laffi, G.; Gentilini, P. The integrin, alpha6beta1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells. Hepatology, 2001, 34(1), 42-49.
49. Ke, A.W.; Shi, G.M.; Zhou, J.; Huang, X.Y.; Shi, Y. H.; Ding, Z.B.; Wang, X.Y.; Devbhandari, R.P.; Fan, J. CD151 amplifies signaling by integrin
50. Devbhandari, R.P.; Shi, G.M.; Ke, A.W.; Wu, F.Z.; Huang, X.Y.; Wang, X.Y.; Shi, Y.H.; Ding, Z.B.; Xu, Y.; Dai, Z.; Fan, J.; Zhou, J. Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin p1 complex in the progression of hepatocellular carcinoma. PLoS One, 2011, 6(9), e24901.
51. Giannelli, G.; Fransvea, E.; Marinosci, F.; Bergamini, C; Colucci, S.; Schiraldi, O.; Antonaci, S. Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin. Am. J. Pathol, 2002, 161(1), 183-193.
52. Mizuno, H.; Ogura, M.; Saito, Y.; Sekine, W.; Sano, R.; Gotou, T.; Oku, T.; Itoh, S.; Katabami, K.; Tsuji, T. Changes in adhesive and migratory characteristics of hepatocellular carcinoma (HCC) cells induced by expression of alpha3beta1 integrin. Biochim. Biophys. Acta., 2008, 1780(3), 564-570.
53. Giannelli, G.; Bergamini, C; Fransvea, E.; Marinosci, F.; Quaranta, V.; Antonaci, S. Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metallo-proteinases activity for migration and invasion. Lab. Invest, 2001, 81(4), 613-627.
54. Begum, N.A.; Mori, M.; Matsumata, T.; Takenaka, K.; Sugimachi, K.; Barnard, G.F. Differential display and integrin alpha 6 messenger RNA overexpression in hepatocellular carcinoma. Hepatology, 1995, 22(5), 1447-1455.
55. Wu, Y.; Qiao, X.; Qiao, S.; Yu, L. Targeting integrins in hepatocellular carcinoma. Exp. Opin. Ther. Targets, 2011, 15(4), 421-437.
56. Liu, T.A.; Jan, Y.J.; Ko, B.S.; Chen, S.C.; Liang, S.M.; Hung, Y.L.; Hsu, C; Shen, T.L.; Lee, Y.M.; Chen, P.F.; Wang, J.; Shyue, S.K.; Liou, J.Y. Increased expression of 14-3-3p promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma. Am. J. Pathol, 2011, 179(6), 2698-2708.
57. Liu, T.A.; Jan, Y.J.; Ko, B.S.; Liang, S.M.; Chen, S.C.; Wang, J.; Hsu, C; Wu, Y.M.; Liou, J.Y. 14-3-3s overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma. PLoS One, 2013, 8(3), e57968.
58. Ko, B.S.; Chang, T.C.; Chen, C.H.; Liu, C.C.; Kuo, C.C.; Hsu, C; Shen, Y.C.; Shen, T.L.; Golubovskaya, V.M.; Chang, C.C.; Shyue, S.K.; Liou, J.Y. Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B. Life Sci., 2010, 86(5-6), 199-206.
59. Ko, B.S.; Chang, T.C.; Liou, J.Y. Focal adhesion kinase as a therapeutic target of bortezomib. Anti-Cancer Agents Med. Chem., 2010, 10(10), 747-752.